AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18855244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 15673850 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric decompression (n = 52)
Number of subjects: 104
Study 15673850 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 52)
Number of subjects: 104
Study 12924677 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (multimodal) treatment
Number of subjects: 579
Study 12924677 — intervention group
Group type: COMPARATOR
Intervention: Medication management
Number of subjects: 579
Study 12924677 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 579
Study 12924677 — intervention group
Group type: EXPERIMENTAL
Intervention: Community care
Number of subjects: 579
Study 11110017 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 11110017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8763370 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentisone HC
Number of subjects: 161
Study 8763370 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 161
Study 1724592 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine 10 mg
Number of subjects: 12
Study 1724592 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 6626112 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 558
Study 6626112 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour Therapy
Number of subjects: 558
Study 6626112 — intervention group
Group type: COMPARATOR
Intervention: Placebo Medication
Number of subjects: 558
Study 6626112 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list Control
Number of subjects: 558
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of PHCCs with MOH hospitals
Number of subjects: 0
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in registration counters’ load
Number of subjects: 0
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleanliness of centers
Number of subjects: 0
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with staff’s behavior
Number of subjects: 0
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Ease in referral
Number of subjects: 0
Study 31241872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental facilities
Number of subjects: 0
Study 29968686 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter therapy program (12 sessions for 6 weeks)
Number of subjects: 60
Study 29968686 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laughter therapy)
Number of subjects: 60
Study 26489482 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized sedation plus daily sedation interruption
Number of subjects: 430
Study 26489482 — intervention group
Group type: COMPARATOR
Intervention: Protocolized sedation
Number of subjects: 430
Study 24517298 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based palliative care
Number of subjects: 8
Study 22953754 — intervention group
Group type: EXPERIMENTAL
Intervention: Online care management
Number of subjects: 151
Study 22953754 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based care management
Number of subjects: 151
Study 22953754 — intervention group
Group type: COMPARATOR
Intervention: Web training
Number of subjects: 151
Study 20231251 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 2871
Study 20231251 — intervention group
Group type: COMPARATOR
Intervention: No vaccination (control)
Number of subjects: 2871
Study 17435399 — intervention group
Group type: EXPERIMENTAL
Intervention: Back-pain-reducing program
Number of subjects: 52
Study 17435399 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 15565494 — intervention group
Group type: EXPERIMENTAL
Intervention: S-L-tryptophan
Number of subjects: 37
Study 15565494 — intervention group
Group type: EXPERIMENTAL
Intervention: S-free tryptophan
Number of subjects: 37
Study 15565494 — intervention group
Group type: EXPERIMENTAL
Intervention: S-CAAs
Number of subjects: 37
Study 15565494 — intervention group
Group type: EXPERIMENTAL
Intervention: S-cortisol
Number of subjects: 37
Study 15565494 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF-cortisol
Number of subjects: 37
Study 15565494 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 37
Study 11813997 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation (4 hours per day)
Number of subjects: 36
Study 11813997 — intervention group
Group type: COMPARATOR
Intervention: Intensive rehabilitation (2 hours per day)
Number of subjects: 36
Study 9726390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg q.d.s.
Number of subjects: 18
Study 9726390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8306050 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone (500 micrograms four times daily) for 1 month
Number of subjects: 19
Study 8306050 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 month
Number of subjects: 19
Study 8306050 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone
Number of subjects: 19
Study 2656624 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole (1 g doses administered intravenously 30-90 min before incision, followed by additional doses at 8 and 16 hours later)
Number of subjects: 51
Study 2656624 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (2 g doses administered intravenously 30-90 min before incision, followed by additional doses at 6 and 12 hours later)
Number of subjects: 51
Study 2656624 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 51
Study 2656624 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 51
Study 1130977 — intervention group
Group type: EXPERIMENTAL
Intervention: Effeminacy Rating Scale
Number of subjects: 32
Study 30406725 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L2-3
Number of subjects: 90
Study 30406725 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L3-4
Number of subjects: 90
Study 30406725 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular intermittent epidural injection at L4-5
Number of subjects: 90
Study 28881493 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 200 mg/day
Number of subjects: 24
Study 28881493 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 400 mg/day
Number of subjects: 24
Study 28881493 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (all doses)
Number of subjects: 24
Study 28881493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 25277459 — intervention group
Group type: EXPERIMENTAL
Intervention: APM-containing dentifrice
Number of subjects: 300
Study 25277459 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 300
Study 24725475 — intervention group
Group type: EXPERIMENTAL
Intervention: PMMA-collagen injections
Number of subjects: 147
Study 24725475 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (Control)
Number of subjects: 147
Study 22467118 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (n=19)
Number of subjects: 30
Study 22467118 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (n=11)
Number of subjects: 30
Study 19201295 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)(2)D(3) treatment for 3 weeks
Number of subjects: 23
Study 19201295 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 23
Study 17465090 — intervention group
Group type: EXPERIMENTAL
Intervention: New drugs for the treatment of type 2 diabetes
Number of subjects: 0
Study 15382007 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 2 micro g/ml fentanyl
Number of subjects: 45
Study 15382007 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 1.5 micro g/ml clonidine
Number of subjects: 45
Study 15382007 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 45
Study 11274542 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CT scans showing ischemic edema
Number of subjects: 786
Study 11274542 — intervention group
Group type: COMPARATOR
Intervention: Patients without early CT findings
Number of subjects: 786
Study 11274542 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoattenuating brain tissue at early CT
Number of subjects: 786
Study 9536833 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin intravenously for 7 days
Number of subjects: 75
Study 9536833 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 75
Study 7878712 — intervention group
Group type: EXPERIMENTAL
Intervention: Virus-inactivated C1-INH concentrates
Number of subjects: 89
Study 7878712 — intervention group
Group type: COMPARATOR
Intervention: Non-virus-inactivated C1-INH concentrates
Number of subjects: 89
Study 2397544 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medical herbs under the principle of Bu‐Shen Yi‐Qi
Number of subjects: 60
Study 2397544 — intervention group
Group type: COMPARATOR
Intervention: Routine treatments such as oryzanol, vitamin B1 and B6
Number of subjects: 60
Study 626430 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural placement of saline solution
Number of subjects: 43
Study 626430 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural blood placement
Number of subjects: 43
Study 31843623 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis (PDD) using hexaminolevulinate instilled in the bladder before flexible cystoscopy with PDD video cystoscope
Number of subjects: 699
Study 31843623 — intervention group
Group type: COMPARATOR
Intervention: White light flexible cystoscope (control group)
Number of subjects: 699
Study 31843623 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis (PDD)
Number of subjects: 699
Study 30054173 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-led VR exposure therapy followed by a four-week internet-administered VR to in-vivo transition program
Number of subjects: 50
Study 30054173 — intervention group
Group type: COMPARATOR
Intervention: Self-led VR exposure therapy followed by the same transition program (after waiting-list)
Number of subjects: 50
Study 28965004 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-communication intervention
Number of subjects: 227
Study 28965004 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support decline during the first year
Number of subjects: 227
Study 25540170 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise (n = 11)
Number of subjects: 37
Study 25540170 — intervention group
Group type: EXPERIMENTAL
Intervention: Education (n = 9)
Number of subjects: 37
Study 25540170 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise and education (n = 8)
Number of subjects: 37
Study 25540170 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 9)
Number of subjects: 37
Study 24575933 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Birth Weight (LBW)
Number of subjects: 1927
Study 24575933 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-for-Gestational Age (SGA)
Number of subjects: 1927
Study 24575933 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm Birth
Number of subjects: 1927
Study 24575933 — intervention group
Group type: COMPARATOR
Intervention: Birth Asphyxia
Number of subjects: 1927
Study 24575933 — intervention group
Group type: COMPARATOR
Intervention: Sepsis Symptoms
Number of subjects: 1927
Study 23095369 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH/r-hLH (150 IU r-hFSH/75 IU r-hLH daily for a maximum of 16 days)
Number of subjects: 35
Study 23095369 — intervention group
Group type: COMPARATOR
Intervention: hMG-HP (150 IU hMG-HP daily for a maximum of 16 days)
Number of subjects: 35
Study 23095369 — intervention group
Group type: EXPERIMENTAL
Intervention: r-hFSH/r-hLH
Number of subjects: 35
Study 23095369 — intervention group
Group type: COMPARATOR
Intervention: hMG-HP
Number of subjects: 35
Study 19095687 — intervention group
Group type: EXPERIMENTAL
Intervention: PVT/VF
Number of subjects: 160
Study 19095687 — intervention group
Group type: EXPERIMENTAL
Intervention: SMVT
Number of subjects: 160
Study 19095687 — intervention group
Group type: COMPARATOR
Intervention: Non-inducible group
Number of subjects: 160
Study 17374817 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug intervention trials
Number of subjects: 283
Study 17374817 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicenter trials
Number of subjects: 283
Study 17374817 — intervention group
Group type: EXPERIMENTAL
Intervention: Industry-sponsored trials
Number of subjects: 283
Study 17374817 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant medication use and comorbidities
Number of subjects: 283
Study 15196518 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual learning training group
Number of subjects: 30
Study 15196518 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 12014814 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine with brief counseling
Number of subjects: 14
Study 9827853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic index diet
Number of subjects: 9
Study 9827853 — intervention group
Group type: EXPERIMENTAL
Intervention: High fibre diet
Number of subjects: 9
Study 9827853 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 9
Study 9827853 — intervention group
Group type: EXPERIMENTAL
Intervention: High GI diet
Number of subjects: 9
Study 7570842 — intervention group
Group type: EXPERIMENTAL
Intervention: melarsoprol treatment
Number of subjects: 1083
Study 1816730 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 44
Study 1816730 — intervention group
Group type: COMPARATOR
Intervention: Placebo-diazepam
Number of subjects: 44
Study 1816730 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 44
Study 1816730 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture
Number of subjects: 44
Study 78529 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 1.5 gm daily
Number of subjects: 20
Study 78529 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 0.75 gm daily
Number of subjects: 20
Study 78529 — intervention group
Group type: COMPARATOR
Intervention: Flutamide 1.0 mg diethylstilbestrol daily
Number of subjects: 20
Study 30222494 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective exercise program
Number of subjects: 65
Study 30222494 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 28221053 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated support model that included antecedent social influence and planning combined with follow‐up performance feedback
Number of subjects: 39
Study 28221053 — intervention group
Group type: COMPARATOR
Intervention: Weekly structured follow‐up interviews
Number of subjects: 39
Study 26082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory-verbal training (20 daily 1-hour sessions over 4 weeks)
Number of subjects: 57
Study 26082889 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial affect discrimination training (20 daily 1-hour sessions over 4 weeks)
Number of subjects: 57
Study 26082889 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU, 4 weeks)
Number of subjects: 57
Study 23787550 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate/magnesium carbonate (CaMg)
Number of subjects: 204
Study 23787550 — intervention group
Group type: COMPARATOR
Intervention: Sevelamer‐hydrochloride (HCl)
Number of subjects: 204
Study 21596243 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cataract surgery
Number of subjects: 520
Study 21596243 — intervention group
Group type: COMPARATOR
Intervention: Sequential bilateral cataract surgery
Number of subjects: 520
Study 18603317 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP measurement
Number of subjects: 401
Study 16886927 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergotamine tartrate
Number of subjects: 40
Study 16886927 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 40
Study 16886927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16886927 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan
Number of subjects: 40
Study 16886927 — intervention group
Group type: COMPARATOR
Intervention: Zolmitriptan
Number of subjects: 40
Study 16886927 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte aggregation
Number of subjects: 40
Study 16821454 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind food challenge with cow's milk
Number of subjects: 43
Study 16821454 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 43
Study 16821454 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintroduction of cow's milk
Number of subjects: 43
Study 12705315 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial soap (0.2% triclosan)
Number of subjects: 238
Study 12705315 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain soap
Number of subjects: 238
Study 10547086 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum chewing
Number of subjects: 17
Study 10547086 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 17
Study 8914461 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cytarabine
Number of subjects: 54
Study 8914461 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose etoposide
Number of subjects: 54
Study 8914461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low-dose therapy (cytarabine and etoposide)
Number of subjects: 54
Study 8914461 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders (CR + PR cases)
Number of subjects: 54
Study 1677282 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate
Number of subjects: 102
Study 1677282 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin
Number of subjects: 102
Study 6881407 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of carbon monoxide level in alveolar air
Number of subjects: 170
Study 29932294 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 120
Study 29932294 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 120
Study 29317896 — intervention group
Group type: EXPERIMENTAL
Intervention: Peony-Glycyrrhiza Decoction (PGD)
Number of subjects: 41
Study 29317896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 25282555 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of prior ECGs
Number of subjects: 130
Study 23590265 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivacaftor (150 mg orally every 12 hours for 48 weeks)
Number of subjects: 52
Study 23590265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 21149654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentostatin 1.0 mg/m²
Number of subjects: 147
Study 21149654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentostatin 1.5 mg/m²
Number of subjects: 147
Study 21149654 — intervention group
Group type: COMPARATOR
Intervention: Control (no pentostatin)
Number of subjects: 147
Study 18348888 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine treatment
Number of subjects: 668
Study 16951831 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal workload prediction models based on age and body mass
Number of subjects: 60
Study 16951831 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-validation of proposed equations
Number of subjects: 60
Study 15449635 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated
Number of subjects: 759
Study 15449635 — intervention group
Group type: COMPARATOR
Intervention: Nonvaccinated
Number of subjects: 759
Study 10866914 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 30
Study 10866914 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 30
Study 9465239 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) measurement of visceral/subcutaneous adipose thickness
Number of subjects: 30
Study 9465239 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography (CT) measurement of visceral/subcutaneous adipose thickness
Number of subjects: 30
Study 9465239 — intervention group
Group type: COMPARATOR
Intervention: Waist-Hip Ratio (W/H)
Number of subjects: 30
Study 7870930 — intervention group
Group type: EXPERIMENTAL
Intervention: remoxipride 100 mg
Number of subjects: 12
Study 7870930 — intervention group
Group type: EXPERIMENTAL
Intervention: remoxipride 100 mg plus biperiden 4 mg
Number of subjects: 12
Study 7870930 — intervention group
Group type: COMPARATOR
Intervention: biperiden 4 mg
Number of subjects: 12
Study 2876573 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol
Number of subjects: 22
Study 2876573 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg celiprolol plus 12.5 mg chlorthalidone
Number of subjects: 22
Study 28865237 — intervention group
Group type: EXPERIMENTAL
Intervention: LY3031207 (225 mg)
Number of subjects: 0
Study 28865237 — intervention group
Group type: EXPERIMENTAL
Intervention: LY3031207 (25 mg, 75 mg, 275 mg)
Number of subjects: 0
Study 28865237 — intervention group
Group type: EXPERIMENTAL
Intervention: LY3031207
Number of subjects: 0
Study 28865237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28865237 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (400 mg)
Number of subjects: 0
Study 27046312 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (50-200 mg per day for 12 weeks)
Number of subjects: 60
Study 27046312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24998293 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance training (Arm A)
Number of subjects: 60
Study 24998293 — intervention group
Group type: COMPARATOR
Intervention: Passive physical therapy (Control Group)
Number of subjects: 60